RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB:PYMX), a biotechnology company focused on developing new therapeutic drugs to treat acute infectious diseases and cardiovascular disorders, announced today that Nicholas Landekic, the Company’s President & CEO will present at the 2011 BIO CEO & Investor Conference on Monday, February 14 at 10:00 a.m. Eastern Time. The conference is being held at the Waldorf-Astoria Hotel in New York City.
